-- Randy Dotinga
THURSDAY, Aug. 18 (HealthDay News) -- A calcium test performed
with the assistance of a CT scanner seems to provide insight into
the likelihood that certain patients at moderate risk of heart
problems will have a heart attack or stroke, researchers say.
The test to detect coronary calcium can help physicians
determine whether the patients should take cholesterol-lowering
drugs to reduce their cardiovascular risks, the study authors
At issue are people who fall into the middle area between those
who are at high risk of heart problems due to factors like high
blood pressure and those who are at low risk. People in the
so-called "gray zone" may have risk factors, such as being
overweight or having high blood sugar levels, but they aren't
considered in great danger.
The question is: Should those in the middle range of risk -- an
estimated 6 million people in the United States -- be prescribed
the anticholesterol drugs known as statins, which often work well
but have side effects?
The study, published in the Aug. 19 issue of
The Lancet, sought to determine whether a test of calcium in the arteries is more helpful at estimating risk than a blood test that examines levels of C-reactive protein.
The researchers tracked 2,083 people for six years. They found
that 13 percent of those with the highest levels of calcium in
their arteries had a heart attack or stroke during that time
period. But just 2 percent of those with high levels of C-reactive
protein -- and no calcium buildup -- had a heart attack or
Not everyone needs a calcium test, said lead study author Dr.
Michael J. Blaha, a cardiology fellow at the Johns Hopkins
University School of Medicine. However, he stated in a Hopkins news
release, "we believe looking for calcification in coronary vessels
in certain patients makes sense in order to predict who may benefit
from statin therapy, because the test gets right to the heart of
the disease we want to treat."
"Our data support recent American Heart Association guidelines, which say it is reasonable to order a coronary calcium scan for adults who are considered to be at intermediate risk of a heart attack over the next 10 years. A high coronary calcium score would indicate that statin therapy would likely be a useful strategy to lower that person's cardiovascular risk," study co-investigator Dr. Roger Blumenthal, director of the Ciccarone Center for the Prevention of Heart Disease at Johns Hopkins University, said in the news release.
Commenting on the study, cardiologist Dr. Vijay Nambi, an
assistant professor at Baylor College of Medicine, said that most
insurance companies don't cover the calcium tests, which cost in
the range of $200-$400. "Sometimes people have to pay for it out of
pocket," said Nambi, who thinks it's a useful test. "It helps
physicians in a lot of respects."
Test results can also help patients make decisions when they're
worried about taking anticholesterol drugs, Nambi added.
For more about
heart disease, visit the U.S. National Library of Medicine.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.